MedPath

Cravit IV 5mg/ml

Registration Number: MAL12020003ACSZ

Approved
Approval ID

347508b51a799a27

Registration Number

MAL12020003ACSZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (2)

50ml mLAvailable
Package Size: 50ml mL
Status: NPRA Approved
100ml mLAvailable
Package Size: 100ml mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

LEVOFLOXACIN HEMIHYDRATEActive
Monograph: levofloxacin hemihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cravit IV 5mg/ml - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform